SeaBridge Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $470K | Buy |
1,868
+433
| +30% | +$93.2K | 0.07% | 143 |
|
|
2026
Q1 | $312K | Hold |
1,435
| – | – | 0.05% | 157 |
|
|
2025
Q4 | $328K | Hold |
1,435
| – | – | 0.05% | 160 |
|
|
2025
Q3 | $332K | Hold |
1,435
| – | – | 0.05% | 163 |
|
|
2025
Q2 | $266K | Hold |
1,435
| – | – | 0.05% | 177 |
|
|
2025
Q1 | $301K | Hold |
1,435
| – | – | 0.06% | 164 |
|
|
2024
Q4 | $255K | Buy |
+1,435
| New | +$264K | 0.05% | 183 |
|
|
2022
Q3 | – | Sell |
-3,300
| Closed | -$505K | – | 131 |
|
|
2022
Q2 | $505K | Sell |
3,300
-286
| -8% | -$43.7K | 0.16% | 112 |
|
|
2022
Q1 | $581K | Buy |
3,586
+286
| +9% | +$41.5K | 0.17% | 117 |
|
|
2021
Q4 | $447K | Hold |
3,300
| – | – | 0.14% | 120 |
|
|
2021
Q3 | $356K | Hold |
3,300
| – | – | 0.12% | 126 |
|
|
2021
Q2 | $372K | Hold |
3,300
| – | – | 0.12% | 124 |
|
|
2021
Q1 | $357K | Hold |
3,300
| – | – | 0.12% | 122 |
|
|
2020
Q4 | $354K | Hold |
3,300
| – | – | 0.13% | 121 |
|
|
2020
Q3 | $289K | Buy |
3,300
+200
| +6% | +$18.8K | 0.11% | 118 |
|
|
2020
Q2 | $304K | Buy |
3,100
+500
| +19% | +$44K | 0.12% | 118 |
|
|
2020
Q1 | $198K | Hold |
2,600
| – | – | 0.09% | 126 |
|
|
2019
Q4 | $230K | Hold |
2,600
| – | – | 0.08% | 128 |
|
|
2019
Q3 | $197K | Hold |
2,600
| – | – | 0.07% | 133 |
|
|
2019
Q2 | $189K | Hold |
2,600
| – | – | 0.06% | 139 |
|
|
2019
Q1 | $210K | Hold |
2,600
| – | – | 0.07% | 137 |
|
|
2018
Q4 | $240K | Hold |
2,600
| – | – | 0.09% | 134 |
|
|
2018
Q3 | $246K | Hold |
2,600
| – | – | 0.06% | 137 |
|
|
2018
Q2 | $241K | Hold |
2,600
| – | – | 0.06% | 138 |
|
|
2018
Q1 | $246K | Hold |
2,600
| – | – | 0.06% | 133 |
|
|
2017
Q4 | $251K | Hold |
2,600
| – | – | 0.05% | 136 |
|
|
2017
Q3 | $231K | Hold |
2,600
| – | – | 0.05% | 140 |
|
|
2017
Q2 | $189K | Hold |
2,600
| – | – | 0.05% | 147 |
|
|
2017
Q1 | $169K | Hold |
2,600
| – | – | 0.04% | 149 |
|
|
2016
Q4 | $163K | Hold |
2,600
| – | – | 0.04% | 148 |
|
|
2016
Q3 | $164K | Hold |
2,600
| – | – | 0.04% | 147 |
|
|
2016
Q2 | $161K | Hold |
2,600
| – | – | 0.04% | 150 |
|
|
2016
Q1 | $149K | Hold |
2,600
| – | – | 0.04% | 157 |
|
|
2015
Q4 | $154K | Hold |
2,600
| – | – | 0.03% | 153 |
|
|
2015
Q3 | $141K | Hold |
2,600
| – | – | 0.03% | 148 |
|
|
2015
Q2 | $175K | Hold |
2,600
| – | – | 0.04% | 143 |
|
|
2015
Q1 | $152K | Hold |
2,600
| – | – | 0.03% | 150 |
|
|
2014
Q4 | $170K | Hold |
2,600
| – | – | 0.03% | 146 |
|
|
2014
Q3 | $150K | Hold |
2,600
| – | – | 0.03% | 132 |
|
|
2014
Q2 | $147K | Hold |
2,600
| – | – | 0.03% | 138 |
|
|
2014
Q1 | $134K | Hold |
2,600
| – | – | 0.03% | 138 |
|
|
2013
Q4 | $137K | Hold |
2,600
| – | – | 0.03% | 146 |
|
|
2013
Q3 | $116K | Hold |
2,600
| – | – | 0.03% | 148 |
|
|
2013
Q2 | $107K | Buy |
+2,600
| New | +$114K | 0.03% | 146 |
|
Other funds holding ABBV
ECSS
ATO
SeaBridge Investment Advisors's ABBV Position: Q2 2026 in Review
SeaBridge Investment Advisors increased its AbbVie (ABBV) stake by 30% in Q2 2026, buying an estimated $93.2K and bringing the position to 1,868 shares worth $470K. The position accounts for 0.07% of the portfolio, ranked #143.
SeaBridge Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. The position peaked at $581K in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- SeaBridge Investment Advisors held 1,868 shares of AbbVie worth $470K as of Q2 2026.
- SeaBridge Investment Advisors bought 433 AbbVie shares in Q2 2026, an estimated $93.2K.
- AbbVie made up 0.07% of SeaBridge Investment Advisors's portfolio in Q2 2026, its #143 holding.
- SeaBridge Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
- SeaBridge Investment Advisors's AbbVie position peaked at $581K in Q1 2022.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on SeaBridge Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.